ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

Nine Saturation Program Planning Contracts Approved

May 9, 1975

CCOP Success Acknowledged, Recompetition Plans Being Made; Cancer Control May Be Added To RFA

April 11, 1986

In Brief: Wittes to Join Bristol-Myers As VP; Friedman Named Acting CTEP Director; Carl Pinsky Leaves

September 23, 1988

Oncology Groups Oppose Proposed Cuts In Medicare Payments For Cancer Drugs

October 11, 2002

NCI Research Plan Proposes Spending $5 Billion In FY2002.

November 3, 2000

Kidney Cancer Group Seeks Proposals; AACR Offers Award

November 17, 1995